01 5Temodar
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 350
2014 Revenue in Millions : 312
Growth (%) : -12%
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : -50.60%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 283
2015 Revenue in Millions : 313
Growth (%) : -10
Main Therapeutic Indication : Others
Currency : USD
2017 Revenue in Millions : 271
2016 Revenue in Millions : 283
Growth (%) : -4
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 214
2017 Revenue in Millions : 271
Growth (%) : -21%
LOOKING FOR A SUPPLIER?